Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.

相似書籍

• Correction: Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD.
  由: Megha Verma, et al.
  出版: (2015-01-01)
• Amelioration of experimental autoimmune encephalomyelitis by anatabine.
  由: Daniel Paris, et al.
  出版: (2013-01-01)
• Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
  由: Jonas Elias Schweig, et al.
  出版: (2017-09-01)
• Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
  由: Bachmeier Corbin, et al.
  出版: (2010-03-01)
• CD40 deficiency mitigates Alzheimer's disease pathology in transgenic mouse models
  由: Volmar Claude-Henry, et al.
  出版: (2006-02-01)